1. Quantum Mechanical Treatment
of a Binding Mode in Thrombin:
Electrostatics of Binding
Cain Morano, Dr.Dave Hangauer SUNY Buffalo
In collaboration with Dr.Gerhard Klebe and Christof Gerlach
Phillips University, Marburg, Germany
3. Project Summary
Unraveling the Thermodynamics of
Molecular Recognition:
Enthalpy/Entropy Compensation
Thrombin & available or novel
inhibitors
Collaboration for ITC, X-ray, and
activity
The “Holy Grail” of Drug Discovery:
Quantification of non-covalent interactions
4. But the question is…
Are we King Arthur’s Court…..or Monty Python?
5. Enthalpy/Entropy Compensation
Non-linear relationship
between enthalpy and entropy
Theory supported by
Dudley Williams’ findings
Degrees of freedom and functional groups affect energetics
6. Enthalpy/Entropy Compensation
0,00 UB10 UB11
N
N O N
-10,00 N O
O
N O
kJ/mol
N
-20,00
-30,00
HN N H2
HN N H2
-40,00
Side-by-side comparison
7. Target Compound
S2
S3
O S1
N
N
H 2N O H
Cl
Merck’s ligand w/ binding regions
8. Novel Binding Mode
Charge-transfer bond
Theory supported by
Auffinger et al.
Novel interaction thought to enhance binding
9. Method Summary
Merck crystal structure 1TA2
MM performed with Sybyl 6.9
QM calculations performed with Gaussian94
Visualized with Molekel and Rastop
Process required multiple tools and skill sets
11. Molecular Modeling
Advantages
Fast
User defined functions and parameters
Rational drug design
Disadvantages
‘Global minima problem’
Requires user intuition and skills
Requires crystal structure
Another tool, not a paradigm shift
13. Quantum Mechanical Calculations
Advantages
Accurate theory to support practice
User defined functions
Detailed physicochemical view
Disadvantages
Computationally expensive
Requires specific skill set
Electron correlation and solvation
Extremely useful for variety of problems
14. Overall method evaluation
Strengths
Fast
Inexpensive
Offers qualitative data
Weaknesses
No solvation factor
No cooperativity
Only a model
Tools that can guide research
15. Math to Model
B3LYP
DFT – total e density, not Ψ
-
6-31G*
Split valence basis set with
polarization function
Builds the model piece-by-piece from atomic to molecular orbital
17. Strategy
Calculate for single residues
Calculate binary, ternary, quaternary interactions
Modify with EDG & EWG
Establish collaboration with CCR at SUNY Buffalo
Iterative and progressive process
18. Streamlining the Process
Ligand truncated to meta-chlorotoluene
Amino acids truncated:
Asp189 to acetate
Trp215-Gly216 to N-methyl-acetamide
Tyr228 to para-hydroxytoluene
Begin with small basis set, low level theory
Simplify then build, consider cost and return
19. Binary Interactions
charge scale… -0.1346 to 0.10548 a.u.
Amide bond from backbone with ligand
Areas of counter-intuitive induced polarization
20. Binary Interactions
-0.17249 to 0.07430 a.u.
-0.1346 to 0.10548 a.u.
Manipulate charge scale for details
25. Atomic Charges (a.u.)
Ligand – m-chlorotoluene
Ligand alone in 4 complex
(+)
1 C -0.515353 -0.520246
3 C 0.160422 0.221632
4 C -0.179828 -0.223321 (-)
5 C -0.059304 -0.044822 (-)
6 C -0.140007 -0.163481
7 C -0.119940 -0.124885
8 C -0.179843 -0.217493 (+)
12 Cl -0.021362 0.002192
Chlorine loses large average electron density
26. Atomic Charges (a.u.)
Tyrosine 228
Tyr alone in 4° complex
1 C -0.529781 -0.520798 (+)
5 C 0.176656 0.185123
6 C -0.188862 -0.186104
8 C -0.191649 -0.180380
10 C 0.345964 0.359216
11 O -0.645287 -0.648089 (+)
13 C -0.156044 -0.149920
15 C -0.184380 -0.187260
Biggest changes were loss of e- density
27. Atomic Charges (a.u.)
Amide bond of peptide backbone
Amide alone in 4° complex (+)
1 C -0.532613 -0.544136
2 C 0.588998 0.599478
6 O -0.508945 -0.520799
7 N -0.580061 -0.546658
8 C -0.310442 -0.304025
(-)
Amide oxygen gains, Amide nitrogen loses e- density
28. Atomic Charges (a.u.)
Aspartic Acid 189
(-)
Asp alone in 4° complex
1 C -0.502038 -0.507450
2 C 0.520851 0.501807
3 O -0.639533 -0.625789
4 O -0.639927 -0.630447
(+)
Oxygens lose e- density, Carbon gains e- density
29. Side-by-Side Comparison
Charge scale -0.1000 to -0.1800
2,5-dichloro m-chloro m-chloro-o-nitro
Other ligands are being synthesized
31. Current Projects
CH3 O CD3 O
H 3C D 3C N
N
OH OH
H 3C D 3C
Cl Cl
T rim e th y la m m o n iu m b u tyric a c id C h lo rid e la b e ls
O OH
N
HN H
HN OH
H O N
OH
N H O
O O OH
R
O Leu T rp Tyr
R= O OH
F A -P h e -R N HN
H
N
HN NH OH
N
NH2 H
O
A rg H is
Synthesis of labels and dipeptide substrates
32. Current Projects
HEK3, HEK4 analysis
using Analyst and MASCOT
DIGE analysis using
DeCyder software